• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

作者信息

Caocci Giovanni, Vacca Adriana, Ledda Antonio, Murgia Francesca, Piras Eugenia, Greco Marianna, Arras Marcella, Atzeni Sandra, Littera Roberto, La Nasa Giorgio

出版信息

Biol Blood Marrow Transplant. 2012 Apr;18(4):652-4. doi: 10.1016/j.bbmt.2011.12.587. Epub 2012 Jan 9.

DOI:10.1016/j.bbmt.2011.12.587
PMID:22240733
Abstract
摘要

相似文献

1
Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病造血干细胞移植后使用达沙替尼进行预防性和抢先性治疗。
Biol Blood Marrow Transplant. 2012 Apr;18(4):652-4. doi: 10.1016/j.bbmt.2011.12.587. Epub 2012 Jan 9.
2
Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.达沙替尼诱导费城染色体阳性急性淋巴细胞白血病患儿第二次缓解后成功进行第二次异基因干细胞移植。
Pediatr Blood Cancer. 2009 Jul;52(7):891-2. doi: 10.1002/pbc.21938.
3
Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病异基因造血干细胞移植后使用达沙替尼进行维持治疗。
Ann Hematol. 2013 Aug;92(8):1137-9. doi: 10.1007/s00277-012-1670-4. Epub 2013 Jan 11.
4
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).费城染色体阳性急性淋巴细胞白血病（Ph+ ALL）的治疗管理。
Hematology Am Soc Hematol Educ Program. 2009:371-81. doi: 10.1182/asheducation-2009.1.371.
5
[Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].[伊马替尼联合化疗治疗费城染色体/BCR-ABL阳性急性淋巴细胞白血病患者的分子反应及预后因素]
Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):120-5. doi: 10.3760/cma.j.issn.0253-2727.2014.02.013.
6
Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP).儿童和青少年费城阳性急性淋巴细胞白血病的异基因造血干细胞移植：意大利儿科血液学和肿瘤学协会（AIEOP）的回顾性多中心研究。
Biol Blood Marrow Transplant. 2012 Jun;18(6):852-60. doi: 10.1016/j.bbmt.2011.10.015. Epub 2011 Oct 20.
7
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
8
Dasatinib plus chemotherapy to achieve full donor chimerism and complete molecular remission in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼联合化疗使一名复发的费城染色体阳性急性淋巴细胞白血病患儿实现完全供者嵌合及完全分子缓解。
Pediatr Blood Cancer. 2013 Oct;60(10):1727-8. doi: 10.1002/pbc.24618. Epub 2013 Jun 4.
9
Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.酪氨酸激酶抑制剂对费城染色体阳性急性淋巴细胞白血病患者预后的影响。
Br J Haematol. 2009 Jun;145(5):581-97. doi: 10.1111/j.1365-2141.2009.07666.x. Epub 2009 Apr 15.
10
Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.达沙替尼使费城染色体阳性的急性淋巴细胞白血病在异基因移植后复发时实现完全供体型嵌合状态并达到缓解。
Bone Marrow Transplant. 2010 Jun;45(6):1125-6. doi: 10.1038/bmt.2009.310. Epub 2009 Oct 26.

引用本文的文献

1
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party.2000年以来初治缓解期Ph阳性急性淋巴细胞白血病移植后结局的改善：欧洲血液与骨髓移植协会急性白血病工作组的一项研究
Hemasphere. 2025 Apr 13;9(4):e70117. doi: 10.1002/hem3.70117. eCollection 2025 Apr.
2
Tyrosine Kinase Inhibitor Post-Allogeneic Stem Cell Transplantation in Adult Philadelphia-Positive B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.酪氨酸激酶抑制剂在成人费城染色体阳性B细胞急性淋巴细胞白血病异基因造血干细胞移植后的应用：现状与未来方向
Curr Issues Mol Biol. 2025 Feb 18;47(2):129. doi: 10.3390/cimb47020129.
3
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions.
费城染色体阳性急性淋巴细胞白血病：十个常见问题。
Leukemia. 2024 Sep;38(9):1876-1884. doi: 10.1038/s41375-024-02319-2. Epub 2024 Jun 20.
4
A pilot study of implication of machine learning for relapse prediction after allogeneic stem cell transplantation in adults with Ph-positive acute lymphoblastic leukemia.一项关于机器学习在成人 Ph 阳性急性淋巴细胞白血病异基因干细胞移植后复发预测中应用的初步研究。
Sci Rep. 2023 Oct 5;13(1):16790. doi: 10.1038/s41598-023-43950-w.
5
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.异基因造血细胞移植治疗费城染色体阳性急性淋巴细胞白血病后的预防性或先发酪氨酸激酶抑制剂治疗。
Int J Hematol. 2023 Aug;118(2):183-192. doi: 10.1007/s12185-023-03556-4. Epub 2023 Feb 20.
6
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults.成人费城染色体阳性急性淋巴细胞白血病的治疗
Cancers (Basel). 2022 Apr 1;14(7):1805. doi: 10.3390/cancers14071805.
7
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼为基础的两步诱导方案治疗费城染色体阳性急性淋巴细胞白血病成人患者。
Blood Adv. 2022 Jan 25;6(2):624-636. doi: 10.1182/bloodadvances.2021004607.
8
A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study.一项基于 BCR/ABL 监测的 Ph+ALL 患者 allo-HCT 前 TKI 策略预防复发的前瞻性临床队列研究。
Leukemia. 2021 Jul;35(7):2054-2063. doi: 10.1038/s41375-020-01090-4. Epub 2020 Nov 17.
9
Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia.新型疗法在成人急性淋巴细胞白血病治疗中的应用。
Curr Hematol Malig Rep. 2020 Aug;15(4):294-304. doi: 10.1007/s11899-020-00591-4.
10
Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper.下一代测序在伴有费城染色体阳性的成人急性淋巴细胞白血病患者中的 BCR-ABL1 激酶结构域突变检测中的应用：一篇立场文件。
Cancer Med. 2020 May;9(9):2960-2970. doi: 10.1002/cam4.2946. Epub 2020 Mar 10.